Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Executive or director change
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SC 13D Stake Beneficial Ownership Report
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 1,250,000 shares at $8.00 ($10,000,000)
  15. 8-K Event Material agreement · Other events
  16. 8-K Event Material agreement · Other events
  17. 424B5 Offering Prospectus
  18. 424B5 Offering Prospectus
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 24 of 33 · 659 filings